PubRank

Zonghai Li

Author PubWeight™ 20.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Peptide ligand-mediated liposome distribution and targeting to EGFR expressing tumor in vivo. Int J Pharm 2008 1.24
2 Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity. Neoplasia 2011 1.07
3 Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma. Cancer Lett 2009 0.99
4 Growth suppression of human hepatocellular carcinoma xenografts by a monoclonal antibody CH12 directed to epidermal growth factor receptor variant III. J Biol Chem 2010 0.98
5 Dickkopf-1 autoantibody is a novel serological biomarker for non-small cell lung cancer. Biomarkers 2010 0.93
6 The synergistic effect of EGFR tyrosine kinase inhibitor gefitinib in combination with aromatase inhibitor anastrozole in non-small cell lung cancer cell lines. Lung Cancer 2012 0.87
7 Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma. J Mater Sci Mater Med 2010 0.84
8 Quantitative analysis of RASSF1A promoter methylation in hepatocellular carcinoma and its prognostic implications. Biochem Biophys Res Commun 2013 0.83
9 Suppression of hLRH-1 mediated by a DNA vector-based RNA interference results in cell cycle arrest and induction of apoptosis in hepatocellular carcinoma cell BEL-7402. Biochem Biophys Res Commun 2005 0.83
10 Synthesis and characterization of stearyl protamine and investigation of their complexes with DNA for gene delivery. Colloids Surf B Biointerfaces 2009 0.83
11 The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Neoplasia 2012 0.83
12 Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer. Carcinogenesis 2013 0.82
13 Identification and characterization of Ch806 mimotopes. Cancer Immunol Immunother 2010 0.81
14 EGFRvIII mRNA detection in the serum of patients with hepatocellular carcinoma. Liver Int 2010 0.81
15 An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression. Cancer Immunol Immunother 2013 0.80
16 A novel EGFR isoform confers increased invasiveness to cancer cells. Cancer Res 2013 0.80
17 Better gene expression by (-)gene than by (+)gene in phage gene delivery systems. Biotechnol Prog 2006 0.79
18 A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2. Biochem Biophys Res Commun 2004 0.77
19 Protein III-based single-chain antibody phage display using bacterial cells bearing an additional genome of a gene-III-lacking helper phage. Biotechniques 2007 0.77
20 Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery. Langmuir 2013 0.77
21 The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III. Cancer Lett 2013 0.76
22 A novel magneto-fluorescent nano-bioprobe for cancer cell targeting, imaging and collection. Appl Biochem Biotechnol 2010 0.76
23 Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy. Acta Biochim Biophys Sin (Shanghai) 2008 0.76
24 Growth and metastasis suppression of glioma xenografts expressing exon 4-deletion variant of epidermal growth factor receptor by monoclonal antibody CH12-mediated receptor degradation. FASEB J 2011 0.75
25 A novel gene delivery system targeting Tie2 for cancer gene therapy. Anticancer Res 2010 0.75